Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 23, 2006
Event: Entry into a Material Definitive Agreement regarding a public offering of common stock.
Key Financial Metrics
This filing details a capital raise rather than operational performance metrics. The filing text does not provide values for revenue, profit, cash flow, margins, or existing debt levels.
- Shares Offered: 2,400,000 shares of common stock.
- Net Proceeds per Share: $22.63 (before deducting transaction expenses).
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 360,000 additional shares.
- Expected Delivery Date: May 30, 2006.
Material Changes
The primary material change is the execution of an underwriting agreement with RBC Capital Markets Corporation, Canaccord Adams Inc., First Albany Capital Inc., and KeyBanc Capital Markets. This agreement facilitates the sale of the aforementioned shares under a Registration Statement on Form S-3 declared effective on May 23, 2006.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release on May 24, 2006, announcing the offering. No specific operational guidance or outlook is provided in this text.
Risks and Contingencies: The Underwriting Agreement includes customary representations, warranties, indemnification, and contribution provisions. The description of terms is qualified by reference to the full agreement filed as Exhibit 10.1.
Investor Verification Checklist
- Verify the final closing date and actual delivery of shares (expected May 30, 2006).
- Confirm the exercise of the 360,000 share over-allotment option by underwriters.
- Review the final prospectus filed on May 24, 2006, for detailed use of proceeds.
- Examine the full Underwriting Agreement (Exhibit 10.1) for specific indemnification liabilities.
- Monitor subsequent filings for the impact of transaction expenses on net proceeds.